annual cash & cash equivalents:
$2.18B+$47.33M(+2.21%)Summary
- As of today (May 29, 2025), NVO annual cash & cash equivalents is $2.18 billion, with the most recent change of +$47.33 million (+2.21%) on December 31, 2024.
- During the last 3 years, NVO annual cash & cash equivalents has risen by +$552.17 million (+33.83%).
- NVO annual cash & cash equivalents is now -28.11% below its all-time high of $3.04 billion, reached on December 31, 2017.
Performance
NVO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$5.65B+$3.46B(+158.60%)Summary
- As of today (May 29, 2025), NVO quarterly cash & cash equivalents is $5.65 billion, with the most recent change of +$3.46 billion (+158.60%) on March 31, 2025.
- Over the past year, NVO quarterly cash & cash equivalents has increased by +$4.73 billion (+517.43%).
- NVO quarterly cash & cash equivalents is now -33.86% below its all-time high of $8.54 billion, reached on September 30, 2024.
Performance
NVO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.2% | +517.4% |
| 3 y3 years | +33.8% | +181.0% |
| 5 y5 years | -5.9% | +291.6% |
NVO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.8% | -33.9% | +517.4% |
| 5 y | 5-year | -5.9% | +33.8% | -33.9% | +530.6% |
| alltime | all time | -28.1% | +1651.5% | -33.9% | +4429.4% |
NVO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $5.65B(+158.6%) |
| Dec 2024 | $2.18B(+2.2%) | $2.18B(-74.4%) |
| Sep 2024 | - | $8.54B(+12.6%) |
| Jun 2024 | - | $7.58B(+728.9%) |
| Mar 2024 | - | $914.80M(-57.2%) |
| Dec 2023 | $2.14B(+17.3%) | $2.14B(-49.9%) |
| Sep 2023 | - | $4.27B(+35.6%) |
| Jun 2023 | - | $3.15B(+44.0%) |
| Mar 2023 | - | $2.19B(+20.1%) |
| Dec 2022 | $1.82B(+11.6%) | $1.82B(-51.6%) |
| Sep 2022 | - | $3.76B(+17.7%) |
| Jun 2022 | - | $3.20B(+59.0%) |
| Mar 2022 | - | $2.01B(+23.2%) |
| Dec 2021 | $1.63B(-22.6%) | $1.63B(-64.5%) |
| Sep 2021 | - | $4.60B(+18.7%) |
| Jun 2021 | - | $3.88B(+332.9%) |
| Mar 2021 | - | $895.74M(-57.5%) |
| Dec 2020 | $2.11B(-9.1%) | $2.11B(-47.5%) |
| Sep 2020 | - | $4.02B(+7.1%) |
| Jun 2020 | - | $3.75B(+160.2%) |
| Mar 2020 | - | $1.44B(-37.8%) |
| Dec 2019 | $2.32B(-3.2%) | $2.32B(-15.6%) |
| Sep 2019 | - | $2.75B(+24.8%) |
| Jun 2019 | - | $2.20B(+61.9%) |
| Mar 2019 | - | $1.36B(-43.2%) |
| Dec 2018 | $2.40B(-21.1%) | $2.40B(-6.1%) |
| Sep 2018 | - | $2.55B(-10.6%) |
| Jun 2018 | - | $2.85B(+64.2%) |
| Mar 2018 | - | $1.74B(-42.8%) |
| Dec 2017 | $3.04B(+14.3%) | $3.04B(+0.3%) |
| Sep 2017 | - | $3.03B(-7.7%) |
| Jun 2017 | - | $3.28B(+36.2%) |
| Mar 2017 | - | $2.41B(-9.4%) |
| Dec 2016 | $2.66B(+7.2%) | $2.66B(+21.5%) |
| Sep 2016 | - | $2.19B(+11.1%) |
| Jun 2016 | - | $1.97B(+168.8%) |
| Mar 2016 | - | $732.53M(-70.4%) |
| Dec 2015 | $2.48B(+5.5%) | $2.48B(+6.1%) |
| Sep 2015 | - | $2.34B(+31.3%) |
| Jun 2015 | - | $1.78B(+105.1%) |
| Mar 2015 | - | $867.50M(-63.1%) |
| Dec 2014 | $2.35B(+18.4%) | $2.35B(+13.9%) |
| Sep 2014 | - | $2.06B(+125.5%) |
| Jun 2014 | - | $914.93M(+88.2%) |
| Mar 2014 | - | $486.10M(-75.5%) |
| Dec 2013 | $1.99B(-3.0%) | $1.99B(+16.4%) |
| Sep 2013 | - | $1.71B(+21.0%) |
| Jun 2013 | - | $1.41B(+14.2%) |
| Mar 2013 | - | $1.23B(-39.7%) |
| Dec 2012 | $2.05B | $2.05B(-12.3%) |
| Sep 2012 | - | $2.33B(+53.8%) |
| Jun 2012 | - | $1.52B(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $1.51B(-35.4%) |
| Dec 2011 | $2.34B(+9.0%) | $2.34B(-14.2%) |
| Sep 2011 | - | $2.72B(+11.6%) |
| Jun 2011 | - | $2.44B(+25.2%) |
| Mar 2011 | - | $1.95B(-9.1%) |
| Dec 2010 | $2.14B(-1.3%) | $2.14B(-5.1%) |
| Sep 2010 | - | $2.26B(+20.8%) |
| Jun 2010 | - | $1.87B(+8.2%) |
| Mar 2010 | - | $1.73B(-20.5%) |
| Dec 2009 | $2.17B(+31.5%) | $2.17B(+8.0%) |
| Sep 2009 | - | $2.01B(+20.5%) |
| Jun 2009 | - | $1.67B(+16.7%) |
| Mar 2009 | - | $1.43B(-13.4%) |
| Dec 2008 | $1.65B(+75.0%) | $1.65B(+22.5%) |
| Sep 2008 | - | $1.35B(+5.9%) |
| Jun 2008 | - | $1.27B(+35.7%) |
| Mar 2008 | - | $938.43M(-0.6%) |
| Dec 2007 | $944.09M(+63.1%) | $944.09M(+18.2%) |
| Sep 2007 | - | $798.55M(+14.7%) |
| Jun 2007 | - | $696.00M(+23.4%) |
| Mar 2007 | - | $564.00M(-2.5%) |
| Dec 2006 | $578.67M(+10.6%) | $578.67M(-3.9%) |
| Sep 2006 | - | $602.00M(+7.2%) |
| Jun 2006 | - | $561.53M(+11.8%) |
| Mar 2006 | - | $502.45M(-3.9%) |
| Dec 2005 | $523.00M(-16.9%) | $523.00M(-7.2%) |
| Sep 2005 | - | $563.69M(+41.8%) |
| Jun 2005 | - | $397.43M(-1.7%) |
| Mar 2005 | - | $404.23M(-35.8%) |
| Dec 2004 | $629.38M(+194.1%) | $629.38M(+27.9%) |
| Sep 2004 | - | $492.11M(+48.8%) |
| Jun 2004 | - | $330.64M(+33.9%) |
| Mar 2004 | - | $246.84M(+15.3%) |
| Dec 2003 | $214.01M(+6.6%) | $214.01M(+6.6%) |
| Dec 2002 | $200.83M(+2.4%) | $200.83M(+2.4%) |
| Dec 2001 | $196.03M(+23.3%) | $196.03M(+23.3%) |
| Dec 2000 | $159.01M(-7.3%) | $159.01M(-7.3%) |
| Dec 1999 | $171.62M(+37.6%) | $171.62M(+37.6%) |
| Dec 1998 | $124.70M(-24.3%) | $124.70M(-24.3%) |
| Dec 1997 | $164.71M(+7.1%) | $164.71M(+7.1%) |
| Dec 1996 | $153.76M(-71.5%) | $153.76M(-71.5%) |
| Dec 1995 | $540.42M(-50.8%) | $540.42M(-50.8%) |
| Dec 1994 | $1.10B(+30.4%) | $1.10B(+30.4%) |
| Dec 1993 | $842.90M(-9.4%) | $842.90M(-9.4%) |
| Dec 1992 | $930.22M(-8.9%) | $930.22M(-8.9%) |
| Dec 1991 | $1.02B(+36.0%) | $1.02B(+36.0%) |
| Dec 1990 | $750.32M(+68.4%) | $750.32M(+68.4%) |
| Dec 1989 | $445.58M(+21.6%) | $445.58M(+21.6%) |
| Dec 1988 | $366.29M(+9.2%) | $366.29M(+9.2%) |
| Dec 1987 | $335.56M(+23.7%) | $335.56M(+23.7%) |
| Dec 1986 | $271.32M(+15.6%) | $271.32M(+15.6%) |
| Dec 1985 | $234.75M(+23.7%) | $234.75M(+23.7%) |
| Dec 1984 | $189.82M | $189.82M |
FAQ
- What is Novo Nordisk A/S annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual cash & cash equivalents year-on-year change?
- What is Novo Nordisk A/S quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly cash & cash equivalents year-on-year change?
What is Novo Nordisk A/S annual cash & cash equivalents?
The current annual cash & cash equivalents of NVO is $2.18B
What is the all time high annual cash & cash equivalents for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual cash & cash equivalents is $3.04B
What is Novo Nordisk A/S annual cash & cash equivalents year-on-year change?
Over the past year, NVO annual cash & cash equivalents has changed by +$47.33M (+2.21%)
What is Novo Nordisk A/S quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NVO is $5.65B
What is the all time high quarterly cash & cash equivalents for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly cash & cash equivalents is $8.54B
What is Novo Nordisk A/S quarterly cash & cash equivalents year-on-year change?
Over the past year, NVO quarterly cash & cash equivalents has changed by +$4.73B (+517.43%)